|
Originally published In Press as doi:10.1074/jbc.M801451200 on May 8, 2008
J. Biol. Chem., Vol. 283, Issue 27, 18621-18626, July 4, 2008
Regulation of I B Kinase-related Kinases and Antiviral Responses by Tumor Suppressor CYLD*
Minying Zhang 1,
Xuefeng Wu 1,
Andrew J. Lee ,
Wei Jin ,
Mikyoung Chang ,
Ato Wright ,
Tadaatsu Imaizumi¶, and
Shao-Cong Sun 2
From the
Department of Immunology, the University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, the Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, and the ¶Department of Vascular Biology, Hirosaki University School of Medicine, Hirosaki 036-8562, Japan
The I B kinase (IKK)-related kinases, IKK and TBK1, participate in the induction of type I interferons (IFNs) during viral infections. Deregulated activation of IKK and TBK1 also contributes to the abnormal cell survival and transformation. However, how these kinases are negatively regulated remains unclear. We show here that the tumor suppressor CYLD has an essential role in preventing aberrant activation of IKK /TBK1. CYLD deficiency causes constitutive activation of IKK /TBK1, which is associated with hyper-induction of IFNs in virus-infected cells. We further show that CYLD targets a cytoplasmic RNA sensor, RIG-I, and inhibits the ubiquitination of this IKK /TBK1 stimulator. Consistent with the requirement of ubiquitination in RIG-I function, CYLD potently inhibits RIG-I-mediated activation of the IFN-β promoter. These findings establish CYLD as a key negative regulator of IKK /TBK1 and suggest a role for CYLD in the control of RIG-I ubiquitination.
Received for publication, February 22, 2008
, and in revised form, May 8, 2008.
* This work was supported, in whole or in part, by National Institutes of Health Grants AI064639, AI057555, and CA94922. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1 and 2.
1 Both authors contributed equally to this work.
2 To whom correspondence should be addressed. Tel.: 713-563-3218; Fax: 713-563-3280; E-mail: ssun{at}mdanderson.org.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. C. Srokowski, J. Masri, N. Hovelmeyer, A. K. Krembel, C. Tertilt, D. Strand, K. Mahnke, R. Massoumi, A. Waisman, and H. Schild
Naturally occurring short splice variant of CYLD positively regulates dendritic cell function
Blood,
June 4, 2009;
113(23):
5891 - 5895.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Mogensen
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Clin. Microbiol. Rev.,
April 1, 2009;
22(2):
240 - 273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sanada, G. Takaesu, R. Mashima, R. Yoshida, T. Kobayashi, and A. Yoshimura
FLN29 Deficiency Reveals Its Negative Regulatory Role in the Toll-like Receptor (TLR) and Retinoic Acid-inducible Gene I (RIG-I)-like Helicase Signaling Pathway
J. Biol. Chem.,
December 5, 2008;
283(49):
33858 - 33864.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|